AKT1 and metabolic dysfunction-associated steatotic liver disease: While the restraint of PI3K/Akt signalling pathway in liver tissues of NAFLD rats was reversed by treatment of PC or SSJZF, indicating SSJZF enhanced PI3K/Akt signalling pathway activity in liver tissues of NAFLD rats.